Posts by tag
AACR
After Covid: AACR call to action to improve cancer care
The American Association for Cancer Research (AACR) has issued ‘a call to action’ to build on lessons learnt from Covid-19 to modernize cancer patient care. The ‘ACCR Report on the Impact of Covid-19 on Cancer Research and Patient Care’, published…
Cancer World Editor heads new AACR cancer prevention working group
Adriana Albini, Editor in Chief of Cancer World, has been appointed Chair of the new Cancer Prevention Working Group (CPWG) of the American Association for Cancer Research (AACR). “I’m so happy and honoured to have this responsibility, and with the…
Malignant: Insights into the process of metastasis and how we can stop it
Why and how do cancer cells travel from their original site to seed new tumours elsewhere in the body, and what can be done to stop them? A series of presentations at the virtual June 2020 annual meeting of the…
AACR: cancer vaccine combination shows clinical activity in advanced solid tumors
According to an industry-funded, preliminary clinical trial presented at the AACR Virtual Annual Meeting currently underway, a personalized cancer vaccine in combination with the PD-L1 inhibitor atezolizumab appears to be well tolerated and to show modest clinical benefit in patients…
Cancer and COVID-19 took the stage at AACR Annual Meeting
It was not scheduled in the original scientific program, but as the new coronavirus pandemic has started spreading all over the world, the American Association for Cancer Research (AACR) dedicated a plenary session of its Annual Meeting to this very…
AACR calls on US Congress to take quick action against COVID-19
The Board of Directors of the American Association for Cancer Research (AACR) wrote to the members of the US Congress urging them to act quickly to overcome the COVID-19 pandemic: «Time is of the essence, and we call on you…
More evidence-based info on off-patent oncology drugs
The American Association for Cancer Research (AACR) has offered help to the U.S. Food and Drug Administration (FDA) on its ambitious Project Renewal, that aims to evaluate accumulated scientific evidence on safety and efficacy of long-standing off-patent oncology drugs, so…